Committed to responsible pain management

Developing innovative and differentiated products for people suffering from pain

At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.

News and Press

Join the Collegium team

See Job Listings

News and Press

  • Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020

    Read More
  • Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain Medicine

    Read More
  • Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update

    Read More
  • Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation

    Read More